傳龍光及合景泰富評估投資者對「凱玥」10.5億美元貸款再融資興趣
《彭博》引述消息人士報道,龍光(03380.HK)及合景泰富(01813.HK)正評估投資者對一筆10.5億美元私人貸款再融資安排的興趣,該貸款由港島豪宅項目「凱玥」作抵押,於2024年8月簽署,初始年化收益率最高可達13%,期限為30個月,並有兩次可選擇的六個月延期。
消息人士表示,兩公司尋求降低借貸成本,目前尚不清楚是否有投資者對再融資安排感興趣。
今早(25日)龍光股價隨大市造好,最高見0.96元,現報0.93元,升4.49%,成交5,894萬股,涉資5,486.2萬元。合景泰富股價現報0.265元,升3.92%,成交184.7萬股,涉資47.96萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.